Results for: Novomix 30 Penfill Injection
Find the latest Novomix 30 Penfill Injection tenders from different organizations. SigmaTenders helps you participate in these online e-Procurement tenders. We provide access to tender details, BOQs, and technical bids, along with bidding support for Novomix 30 Penfill Injection e-tenders. Stay informed with daily email alerts and comprehensive coverage across government websites, GeM, and e-Procurement portals.
Srph031080-human insulin soluble insulin 30 percent and insulin isophane 70 percent 40 iu/ml - 10 ml injection. srph031212-insulin aspart 30 percent and protamine insulin aspart 70 percent suspension 100 i.u / ml, 3 ml cartridge unit:cart. srph031229-monocomponent biosynthetic r-dna insulin solution for injection in 3 ml cartridge for subcutaneous use 70 percent insulin degludec/30 percent insulin aspart penfill 100 units per ml.
For complete deion and other details, please refer to tender
Srph031080-human insulin soluble insulin 30 percent and insulin isophane 70 percent 40 iu/ml - 10 ml injection. srph031212-insulin aspart 30 percent and protamine insulin aspart 70 percent suspension 100 i.u / ml, 3 ml cartridge unit:cart. srph031229-monocomponent biosynthetic r-dna insulin solution for injection in 3 ml cartridge for subcutaneous use 70 percent insulin degludec/30 percent insulin aspart penfill 100 units per ml.
For complete deion and other details, please refer to tender
Srph031080-human insulin soluble insulin 30 percent and insulin isophane 70 percent 40 iu/ml - 10 ml injection. srph031212-insulin aspart 30 percent and protamine insulin aspart 70 percent suspension 100 i.u / ml, 3 ml cartridge unit:cart. srph031229-monocomponent biosynthetic r-dna insulin solution for injection in 3 ml cartridge for subcutaneous use 70 percent insulin degludec/30 percent insulin aspart penfill 100 units per ml.
For complete deion and other details, please refer to tender
Insulin degludec / insulin aspart (r-dna origin) solution for subcutaneous injection. 1ml of the solution contains 100 units insulin degludec and insulin aspart (70 percent soluble insulin degludec and 30 percent soluble insulin aspart) equivalent to 2.56mg salt-free anhydrous insulin degludec and 1.05mg salt-free anhydrous insulin aspart in 3ml penfill cartridge.
For complete deion and other details, please refer to tender
π Procurement Opportunity for Insulin Degludec and Insulin Aspart Solutions π The Ministry of Railways, specifically the Central Government Ministry/Department, is seeking bids for the supply of Insulin Degludec and Insulin Aspart solutions. The solution provided in a 3ml Penfill Cartridge contains 100 units of Insulin Degludec and Insulin Aspart, with 70% being soluble Insulin Degludec and 30% soluble Insulin Aspart, equivalent to 2.56mg and 1.05mg of salt-free anhydrous Insulin Degludec and Insulin Aspart, respectively. π Bid Submission Deadline: May 30, 2024, 10:30 AM Interested bidders are requested to submit their proposals by the specified deadline, ensuring they meet all the technical and financial requirements as outlined in the tender document. Keywords: Insulin Degludec, Insulin Aspart, Insulin Solution, Procurement, Ministry of Railways, Central Government, Diabetes Care, Tender, Bid Submission
Insulin degludec / insulin aspart (r-dna origin) solution for subcutaneous injection. 1ml of the solution contains 100 units insulin degludec and insulin aspart (70 percent soluble insulin degludec and 30 percent soluble insulin aspart) equivalent to 2.56mg salt-free anhydrous insulin degludec and 1.05mg salt-free anhydrous insulin aspart in 3ml penfill cartridge.
For complete deion and other details, please refer to tender
Insulin degludec / insulin aspart (r-dna origin) solution for subcutaneous injection. 1ml of the solution contains 100 units insulin degludec and insulin aspart (70 percent soluble insulin degludec and 30 percent soluble insulin aspart) equivalent to 2.56mg salt-free anhydrous insulin degludec and 1.05mg salt-free anhydrous insulin aspart in 3ml penfill cartridge.
For complete deion and other details, please refer to tender
π Procurement Opportunity for Insulin Degludec and Insulin Aspart Solutions π The Ministry of Railways, specifically the Central Government Ministry/Department, is seeking bids for the supply of Insulin Degludec and Insulin Aspart solutions. The solution provided in a 3ml Penfill Cartridge contains 100 units of Insulin Degludec and Insulin Aspart, with 70% being soluble Insulin Degludec and 30% soluble Insulin Aspart, equivalent to 2.56mg and 1.05mg of salt-free anhydrous Insulin Degludec and Insulin Aspart, respectively. π Bid Submission Deadline: April 15, 2024, 10:30 AM Interested bidders are requested to submit their proposals by the specified deadline, ensuring they meet all the technical and financial requirements as outlined in the tender document. Keywords: Insulin Degludec, Insulin Aspart, Insulin Solution, Medical Tender, Ministry of Railways, Central Government, Diabetes Care, Bid Submission
Need support responding to this opportunity?
Get matched through GetSaarthi for documentation, proposal preparation, compliance readiness, and execution support.
Get Opportunity Matching Supportof your Industry type